Barbinervic acid, classified under the lupane-type structure, has been reported to possess neuroprotective and anti-inflammatory effects, with evidence supporting its role in inhibiting cancer cell proliferation via the MAPK and NF-κB pathways. Here, NFKB1 is linked to cancer.